MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT06065748 | RECRUITING | PHASE3
1050 participants

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-12-11
Completion:
2027-02-19
Conditions
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
No Results Yet
NCT06055920 | ACTIVE_NOT_RECRUITING | NA
1200 participants

The PEERLESS II Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-11-17
Completion:
2026-07-30
Conditions
  • Pulmonary Embolism
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT05960773 | RECRUITING | PHASE2
15 participants

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2024-01-31
Completion:
2028-07-01
Conditions
  • Mesothelioma
  • Malignant Mesothelioma (MM)
  • Early-stage Mesothelioma
  • Subclinical Mesothelioma
  • BRCA1-Associated Protein-1 (BAP1) Mutations
  • Early-stage BAP1-associated Malignancies
Interventions
  • DRUG
No Results Yet
NCT05950464 | RECRUITING | PHASE1
65 participants

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-12-18
Completion:
2027-06-30
Conditions
  • Recurrent Endometrial Carcinoma
  • Recurrent Endometrial Clear Cell Adenocarcinoma
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma
  • Recurrent Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Endometrioid Adenocarcinoma
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05911997 | COMPLETED | PHASE1
38 participants

MTC Versus FMT in for RCDI

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2024-01-08
Completion:
2025-11-13
Conditions
  • Clostridiodies Difficile Infections
Interventions
  • DRUG
No Results Yet
NCT05824364 | COMPLETED | NA
40 participants

Exercise aNd hEArt Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-05-20
Completion:
2025-09-30
Conditions
  • Heart Transplant
Interventions
  • OTHER
No Results Yet
NCT05773274 | RECRUITING | PHASE2
100 participants

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2024-01-12
Completion:
2029-04-30
Conditions
  • Metastatic Digestive System Neuroendocrine Tumor G1
  • Metastatic Digestive System Neuroendocrine Tumor G2
  • Unresectable Digestive System Neuroendocrine Tumor G1
  • Unresectable Digestive System Neuroendocrine Tumor G2
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT05743478 | COMPLETED | NA
542 participants

Forging Hopeful Futures to Reduce Youth Violence

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2023-07-10
Completion:
2026-08-02
Conditions
  • Violence in Adolescence
  • Racism
  • Adolescent Behavior
  • Coping Skills
  • Communication, Social
  • Communication, Personal
  • Violence, Sexual
  • Violence, Non-accidental
  • Violence, Physical
  • Violence, Gender-Based
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page